High dose IVIG has been an appropriate immunomodulatory treatment option for prophylaxis of severe infections in autoimmune and inflammatory diseases [1]. It is suggested that the plasma levels pro-inflammatory cytokines are higher COVID-19 patients with clinical course there a cytokine storm related to severity disease. Therefore, presented as [2]. Mechanisms suggesting benefit SARS-CoV2 thera...